Management of comorbid bipolar disorder and substance use disorders

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The American Journal of Drug and Alcohol Abuse

• Publication date

  2017-03-16

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/00952990.2017.1292279PMID 28301219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

  2016cited by this paper
• Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

  2016cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder.

  2015cited by this paper
• Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study

  2015cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

  2014cited by this paper
• A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.

  2014cited by this paper
• Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.

  2013cited by this paper
• A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.

  2013cited by this paper
• Long-term trajectories of posttraumatic stress disorder in veterans: the role of social resources.

  2013cited by this paper
• Distinguishing Bipolar II Depression From Major Depressive Disorder With Comorbid Borderline Personality Disorder: Demographic, Clinical, and Family History Differences

  2013cited by this paper
• Problematic Boundaries in the Diagnosis of Bipolar Disorder: The Interface with Borderline Personality Disorder

  2013cited by this paper
• An approach to the diagnosis and treatment of patients with bipolar spectrum mood disorders, identifying temperaments.

  2012cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled, Trial of Lamotrigine Therapy in Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence

  2012cited by this paper
• Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD)

  2012cited by this paper
• A randomized, double‐blind, placebo‐controlled clinical trial of acamprosate in alcohol‐dependent individuals with bipolar disorder: a preliminary report

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence.

  2012cited by this paper
• Bipolar II Disorder and Borderline Personality Disorder - co-morbidity or spectrum?

  2012cited by this paper
• Outlining the bases of person-centred integrative diagnosis.

  2011cited by this paper
• A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.

  2010cited by this paper
• Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism

  2010cited by this paper
• Person-Centred Integrative Diagnosis: Conceptual Bases and Structural Model

  2010cited by this paper
• A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

  2009cited by this paper
• A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial.

  2009influential reference
• Diagnostic and treatment considerations: Bipolar patients with comorbid substance use disorders

  2008cited by this paper
• A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.

  2008cited by this paper
• Comorbid Anxiety in Bipolar Disorder Alters Treatment and Prognosis

  2008cited by this paper
• Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.

  2008cited by this paper
• Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study.

  2008cited by this paper
• Building a medical neighborhood for the medical home.

  2008cited by this paper
• Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability.

  2008cited by this paper
• A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.

  2007influential reference
• Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.

  2007cited by this paper
• Buprenorphine: The Basic Pharmacology Revisited

  2007cited by this paper
• A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence

  2007cited by this paper
• Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.

  2007cited by this paper
• Underdiagnosis of Bipolar Disorder in Men with Substance Use Disorder

  2006cited by this paper
• Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2006cited by this paper
• Anxiety disorders and bipolar disorder: a review.

  2006cited by this paper
• Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders

  2006cited by this paper
• Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations.

  2006cited by this paper
• Management of comorbid bipolar disorder and substance abuse.

  2006cited by this paper
• Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study.

  2006cited by this paper
• Management of comorbid bipolar disorder and substance abuse.

  2006cited by this paper
• Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

  2006cited by this paper
• Naltrexone in patients with bipolar disorder and alcohol dependence

  2006cited by this paper
• Psychiatric and Medical Comorbidities of Bipolar Disorder

  2005cited by this paper
• Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

  2005cited by this paper
• Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania.

  2005cited by this paper
• Does recovery from substance use disorder matter in patients with bipolar disorder?

  2005cited by this paper
• A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

  2005cited by this paper
• Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.

  2005cited by this paper
• Introduction: Definitions, measurements, and management in insomnia.

  2004cited by this paper
• Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2004cited by this paper
• Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders

  2004cited by this paper
• Recognition and diagnosis of bipolar disorder.

  2004cited by this paper
• Valproate.

  2003cited by this paper
• A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

  2003cited by this paper
• Atypical antipsychotics and suicide in mood and anxiety disorders.

  2003cited by this paper
• The use of divalproex in alcohol relapse prevention: a pilot study.

  2002cited by this paper
• Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.

  2002cited by this paper
• Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder.

  2002cited by this paper
• Demographic and clinical characteristics of individuals in a bipolar disorder case registry.

  2002cited by this paper
• Quetiapine in bipolar disorder and cocaine dependence.

  2002cited by this paper
• Screening and diagnosis of anxiety and mood disorders in substance abuse patients.

  2001cited by this paper
• Characterizing female bipolar alcoholic patients presenting for initial evaluation.

  2001cited by this paper
• Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

  2000cited by this paper
• Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry.

  2000cited by this paper
• Divalproex sodium in substance abusers with mood disorder.

  2000cited by this paper
• Smoking and mental illness: A population-based prevalence study.

  2000cited by this paper
• Impact of substance abuse on the course and treatment of bipolar disorder.

  2000cited by this paper
• A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

  1999cited by this paper
• Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients.

  1998cited by this paper
• Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

  1998cited by this paper
• Medication compliance among patients with bipolar disorder and substance use disorder.

  1998cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998cited by this paper
• The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI

  1997cited by this paper
• A review of research on the Alcohol Use Disorders Identification Test (AUDIT).

  1997cited by this paper
• Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse.

  1996cited by this paper
• Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.

  1996cited by this paper
• Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.

  1995cited by this paper
• The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients.

  1995cited by this paper
• Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial.

  1995cited by this paper
• The development of a Short Opiate Withdrawal Scale (SOWS).

  1990cited by this paper
• Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

  1990cited by this paper
• Severity of psychosocial stress and outcome of alcoholism treatment.

  1990cited by this paper
• Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

  1989cited by this paper
• The Bech‐Rafaelsen Mania Scale and the Hamilton Depression Scale

  1979cited by this paper
• A Rating Scale for Mania: Reliability, Validity and Sensitivity

  1978cited by this paper

• Clinical practice guidelines for the management of bipolar disorder: 2025 update

  2026cites this paper
• Correlates of alcohol use and alcohol use disorder among youth with bipolar disorder.

  2026cites this paper
• Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches

  2025cites this paper
• Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia.

  2025cites this paper
• Alcohol use disorder: who thinks about addiction? The role of mutual-self-help.

  2025cites this paper
• Harm Perception and Result Awareness Study for Tertiary Prevention in Patients with Comorbidity of Substance Use Disorder and Bipolar Disorder

  2025cites this paper
• Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders.

  2025cites this paper
• Lifetime prevalence of psychiatric comorbidities in patients with bipolar disorder: A systematic review and meta-analysis.

  2024cites this paper
• Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder

  2024cites this paper
• Trastorno afectivo bipolar y trastorno por uso de sustancias. Prevalencia y factores asociados a la patología dual en población general de Colombia

  2024cites this paper
• Maternal cognitive functioning and psychopathology predict quality of parent-child relationship in the context of substance use disorder: A 15-month longitudinal study.

  2024cites this paper
• Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study

  2024cites this paper
• Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder

  2024cites this paper
• Approche transdiagnostique des troubles psychiatriques résistants et complexes

  2024cites this paper
• Current challenges and Indian perspectives in the diagnosis and management of bipolar disorders

  2024cites this paper
• Impact of Comorbid Substance Use in Patients with Bipolar Disorder

  2024cites this paper
• Discontinuity of psychiatric care among patients with bipolar disorder in the Netherlands

  2024cites this paper
• Connections between specific mental health diagnoses of schizophrenia, bipolar disorder and schizoaffective disorder and primary substance use

  2024cites this paper
• Predictors of completion of an adolescent residential alcohol and other drug withdrawal program

  2023cites this paper
• Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records

  2023cites this paper
• Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences

  2023cites this paper
• A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset

  2023cites this paper
• Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort.

  2023cites this paper
• Extracellular Vesicles in Mental Disorders: A State-of-art Review

  2023cites this paper
• Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample

  2023cites this paper
• Relapse among MHCUs after a Short-Term Admission in an Acute Psychiatric Unit: Primary Caregivers’ Perspective

  2023cites this paper
• Differences in Substance Use Disorders and Other Mental Disorders in Mental Health and Addiction Settings: Sociodemographic, Clinical, Drug Treatment, and Gender Differences

  2022cites this paper
• Schema Therapy for Patients with Bipolar Disorder: Theoretical Framework and Application

  2022cites this paper
• Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications

  2022cites this paper
• Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study

  2022cites this paper
• Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders.

  2022cites this paper
• Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité

  2022cites this paper
• Impaired risk avoidance in bipolar disorder and substance use disorders.

  2022cites this paper
• Outcomes of Hospitalized Acute Alcoholic Hepatitis (AH) in Patients With Bipolar 1 Disorder (B1D)

  2022cites this paper
• The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder

  2022cites this paper
• NDT_A_344356 29..46

  2022cites this paper
• Eosinophils to Lymphocytes Ratio (ELR) as a Potential Inflammatory Biomarker in Patients with Dual Diagnosis of Bipolar and Alcohol Use Disorders: A Retrospective Cohort Study

  2022cites this paper
• Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management

  2022cites this paper
• Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample.

  2022cites this paper
• Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran

  2022cites this paper
• Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Co-existing Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments

  2022cites this paper
• The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

  2022cites this paper
• Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

  2022cites this paper
• Perceived stress among patients with depression and anxiety in remission during the COVID-19 pandemic

  2022cites this paper
• Citicoline: pharmacological and clinical review, 2022 update

  2022cites this paper
• Establishing a System of Care for Severe and Refractory Dual Disorder in the State of Hawai'i.

  2022cites this paper
• Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders.

  2021cites this paper
• Genetic contributions to bipolar disorder: current status and future directions

  2021cites this paper
• Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC)

  2021cites this paper
• Longitudinal grey matter changes following first episode mania in bipolar I disorder: A systematic review.

  2021cites this paper
• Psychosocial Rehabilitation Interventions in the Treatment of Schizophrenia and Bipolar Disorder

  2021cites this paper
• Bipolar Disorder and Comorbid Use of Illicit Substances

  2021influential citation
• Comorbid Bipolar and Alcohol Use Disorder—A Therapeutic Challenge

  2021cites this paper
• Advances in the psychopharmacotherapy of bipolar disorder type I

  2021cites this paper
• A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder

  2021cites this paper
• Comorbid Conditions in Relation to Controlled Substance Abuse.

  2020cites this paper
• Treating Comorbid Substance Use and Psychosis

  2020cites this paper
• A Prospective Comparison of Bipolar I and II Subjects With and Without Comorbid Alcohol Dependence From the COGA Dataset

  2020cites this paper
• Clinical Correlates of Alcohol Use Disorder in Depressed Patients with Unipolar and Bipolar Disorder

  2019cites this paper
• Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder.

  2019cites this paper
• Gender-related differences in patients with bipolar disorder: a nationwide study

  2019cites this paper
• Treatment of substance use disorders with co-occurring severemental health disorders.

  2019cites this paper
• Pharmacotherapies for co‐occurring substance use and bipolar disorders: A systematic review

  2019cites this paper
• The Treatment of Cannabis Use Disorder

  2019cites this paper
• Cannabis use: A co-existing condition in first-episode bipolar mania patients.

  2019cites this paper
• The interactive effect of the serotonin transporter genotype and drug use on suicidal behaviors in patients diagnosed with bipolar disorder.

  2019cites this paper
• CONSENSUS ASPECTS OF COUNSELING SUPERVISION PRACTICES IN DRUG TREATMENT CENTRE

  2019cites this paper
• Differences in substance use, psychiatric disorders and social factors between Mexican adolescents and young adults

  2018cites this paper
• Emotional Availability, Neuropsychological Functioning, and Psychopathology: The Context of Parental Substance Use Disorder

  2018cites this paper
• Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package

  2018cites this paper
• Medical Comorbidities in Bipolar Disorder

  2018cites this paper
• Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes

  2018cites this paper
• Psychiatric Comorbidity of Cannabis Use Disorder

  2018cites this paper
• Stimulants and Mood Disorders

  2018cites this paper
• The Compelling and Persistent Problem of Bipolar Disorder Disguised as Major Depression Disorder: An Integrative Review

  2018cites this paper
• The Diagnosis and Treatment of Comorbid Bipolar and Substance Use Disorders

  2017influential citation
• Person-Centered Treatment to Optimize Psychiatric Medication Adherence

  2017cites this paper
• Epilogue to Dual Diagnosis Special Issue

  2017cites this paper